HOME ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE STORY OF OUR FIRM

Saturday, July 19, 2008

Clinical Trials for Mesothelioma Patients: AZD2171 Contact Information

Read more here to obtain contact information for the facilities participating in the current clinical trial being conducted to study the effects of AZD2171 for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only

California:
City of Hope Comprehensive Cancer Center; 800-826-4673 Contra Costa Regional Medical Center; 925-370-5114 Tower Cancer Research Foundation; 310-888-8680 University of California Davis Cancer; 916-734-3089 USC/Norris Comprehensive Cancer Center; 323-865-0451
Illinois:
Cardinal Bernardin Cancer Center; 708-226-4357 Central Springfield Hematology Oncology Center; 217-525-2500 Decatur Memorial Hospital Cancer Care; 217-876-6601 Evanston Northwestern Healthcare – Evanstown Hospital; 847-570-1381 Ingalls Cancer Care Center at Ingalls Memorial Hospital; 708-915-6747 Oncology Hematology Associates of Central Illinois, PC; 309-243-1000 University of Chicago Cancer Research Center; 773-834-7424
Indiana:
CCOP - Northern Indiana CR Consortium; 574-647-3353 Fort Wayne Medical Oncology and Hematology; 260-484-8830
Michigan:
Oncology Care Associates, PLLC; 269-985-0029
Pennsylvania:
Penn State Cancer Institute at Milton; 717-531-3779
Wisconsin:
Medical College of Wisconsin Cancer Center; 414-805-4380
Toronto, Ontario (Canada):
Princess Margaret Hospital: 416-946-4645

Courtesy of ClinicalTrials.gov,

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney


Mesothelioma & Asbestosis Mortalities Across the US: 1979-2001 (c/o EWG)

“We have seen first-hand how asbestos has wreaked havoc on Americans working in naval shipyards, automobile plants, and the construction industry. Most often this is through their employers’ conscious choice for profits over a worker's health.”

-- Joseph Patrick Williams, a trial attorney in the Asbestos Litigation department of Weitz & Luxenberg

CONTACT WEITZ & LUXENBERG FOR A FREE LEGAL EVALUATION OF YOUR CASE

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


Mesothelioma
Symptoms, Stages, Treatment of Mesothelioma
Treatment
IN THIS SECTION
Antineoplaston therapy for mesothelioma patients
Antineoplaston trial for mesothelioma patients
Antineoplaston clinical trial for mesothelioma
Antineoplaston therapy for mesothelioma patients
Antineoplaston test for mesothelioma patients
AZD2171 therapy for mesothelioma patients
AZD2171 trial for mesothelioma patients
AZD2171 trial for mesothelioma disease
Mesothelioma patient study of AZD2171 effects
AZD2171 therapy for mesothelioma patients
Contact info for mesothelioma AZD2171 facilities
Current Bortezomib therapy for mesothelioma
Bortezomib trial description for mesothelioma
Outcomes of Bortezomib against mesothelioma cancer
Criteria of Bortezomib study on mesothelioma test
Effects of Bortezomib trial on mesothelioma cancer
Bortezomib therapy for mesothelioma patients
Current Dasatinib therapy for mesothelioma
NSC 732517 trial description for mesothelioma
NSC 732517 trial for mesothelioma patients
Eligibility for mesothelioma trial of NSC 732517
Mesothelioma patient profile for NSC 732517 trial
Mesothelioma therapy criteria to test NSC 732517
Information on NSC 732517 trial for mesothelioma
Bortezomib therapy for mesothelioma patients
Bortezomib and Cisplatin in mesothelioma trial
Cisplatin therapy for mesothelioma patients
Bortezomib and Cisplatin in mesothelioma trial
Mesothelioma therapy criteria to test NSC 732517
Information on NSC 732517 trial for mesothelioma
Current Imatinib therapy for mesothelioma patients
Imatinib Mesylate trial for mesothelioma patients
Outcomes of Imatinib against mesothelioma cancer
Recruitment data to test Imatinib on mesothelioma
Inclusion standard in Imatinib mesothelioma trial
Exclusion standard in Imatinib mesothelioma trial
Contact info for Imatinib mesothelioma study
Current Immunotoxin therapy: mesothelioma patients
Immunotoxin therapy for mesothelioma patients
Objectives of Immunotoxin trial on mesothelioma
Study outline for Immunotoxin mesothelioma trial
Disease traits in Immunotoxin mesothelioma trial
Patient traits: Immunotoxin mesothelioma trial
Contact info for Immunotoxin mesothelioma program
Early mesothelioma symptoms from Canada asbestos
Canada study criteria of early mesothelioma traits
Contact info for mesothelioma program in Canada
Cisplatin and Pemetrexed therapy for mesothelioma
Description of Pemetrexed mesothelioma study
Inclusion standard in Pemetrexed mesothelioma test
Exclusion standard in Pemetrexed mesothelioma test
Contact info for Pemetrexed mesothelioma study
NGR for mesothelioma
NGR drug trials against mesothelioma
NGR for mesothelioma study
Exclusion criteria for mesothelioma NGR study
Contact for Antineoplaston test on mesothelioma
Pazopanib for mesothelioma patients
Pazopanib for mesothelioma study
Pazopanib inclusion criteria at mesothelioma trial
Patient criteria for mesothelioma Pazopanib study
Pazopanib for mesothelioma therapy
Pemetrexed drug for mesothelioma patients
Pemetrexed drug study for mesothelioma patients
Pemetrexed and cisplatin for mesothelioma patients
Pemetrexed study outline for mesothelioma patients
Pemetrexed disodium drug trial for mesothelioma
Pemetrexed trials for mesothelioma patients
Pemetrexed trials for mesothelioma patients
Contact info: Pemetrexed trial for mesothelioma
Vitamin B12 test on mesothelioma patients
Vitamin B12 study on mesothelioma patients
Outcome of Vitamin B12 on mesothelioma patients
Vitamin B12 outline for mesothelioma study
Patient criteria for B12 study on mesothelioma
Criteria of Vitamin B12 therapy on mesothelioma
Contact info of mesothelioma clinical trial of B12
Novartis LBH589 for mesothelioma
Novartis LBH589 for mesothelioma study
LBH589 trial for mesothelioma
Clinical LBH589 for mesothelioma
Clinical trial for esophageal cancer, mesothelioma
Clinical trial of hTNF for mesothelioma
Valproate for Mesothelioma
Vandetanib tested for mesothelioma
Vorinostat tested for mesothelioma
see also:

Bortezomib trial description for mesothelioma Description of program to treat mesothelioma patients with Bortezomib
Description of study to test Bortezomib effectiveness on mesothelioma

Exclusion standard in Pemetrexed mesothelioma test Exclusion criteria to treat mesothelioma patients with Pemetrexed
Patient exclusion criteria for Pemetrexed mesothelioma clinical trial

Clinical trials on asbestos illness: mesothelioma Info about clinical trials on mesothelioma, an asbestos illness
Information on clinical trials of the asbestos illness, mesothelioma

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question